The ankle-brachial index (ABI) is a simple, painless test comparing blood pressure at the ankle to blood pressure at the arm. The ratio indicates whether blood is flowing properly through the arteries of the legs. If leg pressure is significantly lower than arm pressure, blockages or narrowing in the arteries (peripheral artery disease — PAD) are suspected. Procedure: lie on table; blood pressure cuffs placed on arms and ankles; Doppler ultrasound used to detect pulses; takes 15-20 minutes; results immediate. Adults with diabetes have 2-4x higher PAD risk than non-diabetic adults — ABI testing is important. ABI values: normal 0.9-1.3, borderline 0.91-0.99, mild PAD 0.7-0.9, moderate PAD 0.4-0.7, severe PAD under 0.4, non-compressible over 1.3 (calcified arteries; common in diabetes; ABI may not be accurate — alternative testing needed). For adults with non-compressible findings, toe-brachial index (TBI) more accurate. Why PAD important in diabetes: 2-4x higher risk, increases foot ulcer and amputation risk, marker for systemic atherosclerosis, often asymptomatic (peripheral neuropathy can mask claudication), increases cardiovascular mortality, treatable if detected, diabetes accelerates progression, combined with neuropathy increases foot complications. Detection enables intervention: cardiovascular risk reduction (statins, ACE inhibitors, antiplatelet therapy), smoking cessation, exercise therapy, occasionally revascularization. ABI is standard initial screening test. ADA recommendations: at diabetes diagnosis (baseline), every 5 years thereafter for adults without PAD, annually for adults over 50, annually with risk factors (smoking, hypertension, dyslipidemia, family history), when symptoms develop. Annual diabetic foot exam should include ABI assessment in adults over 50. Cost: $50-200 typically; covered by insurance with medical necessity.
ABI Interpretation
| ABI Value | Interpretation | Action |
|---|---|---|
| 0.9-1.3 | Normal | Periodic monitoring |
| 0.91-0.99 | Borderline | Risk factor management; reassess |
| 0.7-0.9 | Mild PAD | Treatment; lifestyle |
| 0.4-0.7 | Moderate PAD | Treatment; consider vascular referral |
| under 0.4 | Severe PAD | Urgent vascular referral; intervention often needed |
| over 1.3 | Non-compressible | Alternative testing (TBI, ultrasound) |
PAD Symptoms in Diabetes
- Claudication: leg pain with walking; relieved by rest. CLASSIC but often masked in diabetes due to neuropathy.
- Foot pain at rest: especially at night.
- Non-healing foot wounds: due to poor blood flow.
- Cold feet compared to warm hands.
- Pale or bluish skin color in legs.
- Hair loss on legs/feet.
- Shiny skin.
- Diminished pulses in feet.
- Erectile dysfunction — related to systemic vascular disease.
- Asymptomatic: many adults with diabetes have PAD without typical symptoms.
PAD Treatment Approaches
- Risk factor management: statins, ACE inhibitors, antiplatelet therapy (aspirin, clopidogrel), glucose control.
- Smoking cessation: critical — major modifiable risk factor.
- Exercise therapy: supervised walking program; improves claudication.
- Cilostazol: medication for claudication; improves walking distance.
- Pentoxifylline: alternative for claudication.
- Revascularization: angioplasty, stenting, bypass for severe disease or critical limb ischemia.
- Wound care: for foot complications.
- Aggressive cardiovascular risk reduction: PAD = high CV risk.
- SGLT2 inhibitors: cardiovascular benefits in diabetes.
When to Test ABI
- At diabetes diagnosis — baseline.
- Every 5 years for adults without PAD.
- Annually for adults over 50 with diabetes.
- Annually with risk factors.
- New leg pain or claudication.
- Non-healing foot wounds.
- Cold feet.
- Foot color changes.
- Diminished pulses on physical exam.
- Adults with peripheral neuropathy.
- Pre-operative for high-risk procedures.
- Cardiovascular events.
The Bottom Line
The ankle-brachial index (ABI) is a simple, painless test comparing blood pressure at the ankle to blood pressure at the arm. The ratio indicates whether blood is flowing properly through the arteries of the legs. If leg pressure is significantly lower than arm pressure, blockages or narrowing in the arteries (peripheral artery disease — PAD) are suspected. Procedure: lie on table; blood pressure cuffs placed on arms and ankles; Doppler ultrasound used to detect pulses; takes 15-20 minutes; results immediate. Adults with diabetes have 2-4x higher PAD risk than non-diabetic adults — ABI testing is important. ABI values: normal 0.9-1.3, borderline 0.91-0.99, mild PAD 0.7-0.9, moderate PAD 0.4-0.7, severe PAD under 0.4, non-compressible over 1.3 (calcified arteries common in diabetes due to medial calcification; ABI may not be accurate — alternative testing needed). For non-compressible findings, toe-brachial index (TBI) more accurate. Why PAD important in diabetes: 2-4x higher risk, increases foot ulcer and amputation risk substantially, marker for systemic atherosclerosis (also affects heart, brain), often asymptomatic (peripheral neuropathy can mask claudication leg pain with exercise), increases cardiovascular mortality, treatable if detected, diabetes accelerates progression. PAD Symptoms (often masked in diabetes): claudication (leg pain with walking, relieved by rest), foot pain at rest especially night, non-healing foot wounds, cold feet, pale or bluish skin color, hair loss on legs/feet, shiny skin, diminished pulses, erectile dysfunction. Many adults asymptomatic. Treatment: risk factor management (statins, ACE inhibitors, antiplatelet therapy — aspirin or clopidogrel, glucose control), smoking cessation (critical — major modifiable risk factor), exercise therapy (supervised walking improves claudication), cilostazol or pentoxifylline for claudication, revascularization (angioplasty, stenting, bypass) for severe disease or critical limb ischemia, wound care for foot complications, aggressive cardiovascular risk reduction (PAD = high CV risk), SGLT2 inhibitors (cardiovascular benefits in diabetes). ABI is standard initial screening test. ADA recommendations: at diabetes diagnosis (baseline), every 5 years thereafter for adults without PAD, annually for adults over 50, annually with risk factors (smoking, hypertension, dyslipidemia, family history), when symptoms develop. Annual diabetic foot exam should include ABI assessment in adults over 50. Cost: $50-200 typically; covered by insurance with medical necessity. For adults with type 2 diabetes, ABI screening is essential preventive care — detects treatable vascular disease before symptoms develop. See our broader peripheral artery disease and diabetes guide for context.
